Paediatric Cardiac Anaesthesia in the UK - Current Controversies

This paper is a personal view by the authors of some of the major controversies that currently face paediatric cardiac anaesthetists in the United Kingdom (UK); it should be noted that our views are not necessarily representative of other UK anaesthetists working in this field. The issues that we have chosen to discuss have been the subject of important changes in national or local policies in the last few years, and that have had (or will have) a substantial impact on our clinical practice.

References

• 1 Bristol Royal Infirmary Inquiry .http://www.bristol-inquiry.org/. 2001
• 2 Spiegelhalter D J. Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data.  Br Med J. 2001;  323 1-5
• 3 Hannan E L, Racz M, Kavey R E. et al . Pediatric cardiac surgery: the effect of hospital and surgeon volume on in-hospital mortality.  Pediatr. 1998;  101 963-969
• 4 Jenkins K J, Newburger J W, Lock J E. et al . In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload.  Pediatr. 1995;  95 323-330
• 5 Sollano J A, Gelijns A C, Moskowitz A J. et al . Volume-outcome relationships in cardiovascular operations: New York State, 1990 - 1995.  J Thorac Cardiovasc Surg. 1999;  117 419-428
• 6 Hasan A, Pozzi M, Hamilton J RL. New surgical procedures: can we minimise the learning curve?.  Br Med J. 2000;  320 171-173
• 7 Odegard K C, Modest S A, Laussen P C. A survey of parental satisfaction during parent present induction of anaesthesia for children undergoing cardiovascular surgery.  Paediatr Anaesth. 2002;  12 261-266
• 8 Russell I A, Miller Hance W C, Gregory G. et al . The safety and efficacy of sevoflurane anesthesia in infants and children with congenital heart disease.  Anesth Analg. 2001;  92 1152-1158
• 9 Rosenthal D N, Friedman A H, Kleinman C S. et al . Thromboembolic complications after Fontan operations.  Circulation. 1995;  92 II287-II293
• 10 Booker P D. Editorial: Opioids in paediatric cardiac anaesthesia.  Br J Anaesth. 2000;  84 547-549
• 11 Duncan H P, Cloote A, Weir P M. et al . Reducing stress responses in the pre-bypass phase of open heart surgery in infants and young children: a comparison of different fentanyl doses.  Br J Anaesth. 2000;  84 556-564
• 12 Davis P J, Wilson A S, Siewers R D. et al . The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair.  Anesth Analg. 1999;  89 904-908
• 13 Ahonen J, Olkkola K T, Hynynen M. et al . Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery.  Br J Anaesth. 2000;  85 533-540
• 14 Koren G, Crean P, Klein J. et al . Sequestration of fentanyl by the cardiopulmonary bypass (CPBP).  Eur J Clin Pharmacol. 1984;  27 51-56
• 15 Lake C L. Fast tracking the paediatric cardiac surgical patient.  Paediatr Anaesth. 2000;  10 231-236
• 16 Peterson K L, DeCampli W M, Pike N A. et al . A report of two hundred twenty cases of regional anesthesia in pediatric cardiac surgery.  Anesth Analg. 2000;  90 1014-1019
• 17 Miller B E, Tosone S R, Tam V K. et al . Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations.  Ann Thorac Surg. 1998;  66 535-540
• 18 Alvarez J M, Jackson L R, Chatwin C, Smolich J J. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.  J Thorac Cardiovasc Surg. 2001;  122 457-463
• 19 Codispoti M, Mankad P S. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice.  Perfusion. 2000;  15 191-201
• 20 Carrel T P, Schwanda M, Vogt P R, Turina M I. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high dose regimen only.  Ann Thorac Surg. 1998;  66 153-158
• 21 Coon P D, Rychik J, Novello R T. et al . Thrombus formation after the Fontan operation.  Ann Thorac Surg. 2001;  71 1990-1994
• 22 Plessis A J du, Jonas R A, Wypij D. et al . Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants.  J Thorac Cardiovasc Surg. 1997;  114 991-1001
• 23 Hickey P R. Neurologic sequelae associated with deep hypothermic circulatory arrest.  Ann Thorac Surg. 1998;  65 S65-S69
• 24 Sakamoto T, Zurakowski D, Duebener L F. et al . Combination of alpha-stat strategy and hemodilution exacerbates neurologic injury in a survival piglet model with deep hypothermic circulatory arrest.  Ann Thorac Surg. 2002;  73 180-189
• 25 Kurth C D, O’Rourke M M, O’Hara I B. Comparison of pH-stat and alpha-stat cardiopulmonary bypass on cerebral oxygenation and blood flow in relation to hypothermic circulatory arrest in piglets.  Anesthesiology. 1998;  89 110-118
• 26 Bellinger D C, Jonas R A, Rappaport L A. et al . Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass.  N Engl J Med. 1995;  332 549-555
• 27 Kirkham F J. Recognition and prevention of neurological complications in pediatric cardiac surgery.  Pediatr Cardiol. 1998;  19 331-345
• 28 Pua H L, Bissonnette B. Cerebral physiology in paediatric cardiopulmonary bypass.  Can J Anaesth. 1998;  45 960-978
• 29 Forbess J M, Visconti K J, Bellinger D C. et al . Neurodelopmental outcomes after biventricular repair of congenital heart defects.  J Thorac Cardiovasc Surg. 2002;  123 631-639
• 30 Kurth C D, O’Rourke M M, O’Hara I B, Uher B. Brain cooling efficiency with pH-stat and alpha-stat cardiopulmonary bypass in newborn pigs.  Circulation. 1997;  96 359-363
• 31 Allen B S, Rahman S, Ilbawi M N. et al . Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury.  Ann Thorac Surg. 1997;  64 1381-1388
• 32 Zimmerman A A, Burrows F A, Jonas R A, Hickey P R. The limits of detectable cerebral perfusion by transcranial Doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1997;  114 594-600
• 33 Nollert G, Sperling J, Sakamoto T. et al . Higher hematocrit improves liver blood flow and metabolism during cardiopulmonary bypass in piglets.  Thorac Cardiovasc Surg. 2001;  49 226-230
• 34 Duebener L F, Sakamoto T, Hatsuoka S. et al . Effects of hematocrit on cerebral microcirculation and tissue oxygenation during deep hypothermic bypass.  Circulation. 2001;  104 I-260-I-264
• 35 Bronicki R A, Backer C L, Baden H P. et al . Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children.  Ann Thorac Surg. 2000;  69 1490-1495
• 36 Volk T, Schmutzler M, Engelhardt L. et al . Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass.  Crit Care Med. 2001;  29 2137-2142
• 37 Azab S R El, Rosseel P M, Lange J J de. et al . Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery.  Br J Anaesth. 2002;  88 496-501
• 38 Mott A R, Fraser C D, Kusnoor A V. et al . The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass.  J Am Coll Cardiol. 2001;  37 1700-1706
• 39 Turkoz A, Cigli A, But K. et al . The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.  J Cardiothorac Vasc Anesth. 2001;  15 603-610
• 40 Schurr U P, Zund G, Hoerstrup S P. et al . Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass.  Ann Thorac Surg. 2001;  72 1316-1320
• 41 Chaney M A. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations.  Chest. 2002;  121 921-931
• 42 Langley S M, Chai P J, Jaggers J J, Ungerleider R M. Preoperative high dose methylprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest.  Eur J Cardiothorac Surg. 2000;  17 279-286
• 43 Shum-Tim D, Tchervenkov C I, Jamal A M. et al . Systemic steroid pretreatment improves cerebral protection after circulatory arrest.  Ann Thorac Surg. 2001;  72 1465-1471
• 44 Kanellopoulos G K, Kato H, Wu Y. et al . Neuronal cell death in the ischemic spinal cord.  Ann Thorac Surg. 1997;  64 1279-1285
• 45 Naik S K, Knight A, Elliott M. A prospective randomized study of a modifed technique of ultrafiltration during pediatric open-heart surgery.  Circulation. 1991;  84 III422-III431
• 46 Friesen R H, Campbell D N, Clarke D R, Tornabene M A. Modified ultrafiltration attentuates dilutional coagulopathy in pediatric open heart operations.  Ann Thorac Surg. 1997;  64 1787-1789
• 47 Draaisma A M, Hazekamp M G, Frank M. et al . Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery.  Ann Thorac Surg. 1997;  64 521-525
• 48 Yndgaard S, Andersen L W, Andersen C. et al . The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass.  J Cardiothorac Vasc Anesth. 2000;  14 399-401
• 49 Elliott M J. Ultrafiltration and modified ultrafiltration in pediatric open heart operations.  Ann Thorac Surg. 1993;  56 1518-1522
• 50 Kameyama T, Ando F, Okamoto F. et al . The effect of modified ultrafiltration in pediatric open heart surgery.  Ann Thorac Cardiovasc Surg. 2000;  6 19-26
• 51 Thompson L D, McElhinney D B, Findlay P. et al . A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery.  J Thorac Cardiovasc Surg. 2001;  122 209-211
• 52 Maluf M A, Mangia C, Silva C. et al . Conventional and conventional plus modified ultrafiltration during cardiac surgery in high-risk congenital heart disease.  J Cardiovasc Surg (Torino). 2002;  42 465-473
• 53 Wang M J, Chiu I S, Hsu C M. et al . Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations.  Ann Thorac Surg. 1996;  61 651-656
• 54 Ramamoorthy C, Lynn A M. Con: The use of modified ultrafiltration during pediatric cardiovascular surgery is not a benefit.  J Cardiothorac Vasc Anesth. 1998;  12 483-485
• 55 Rosen D A, Morris J L, Rosen K R. et al . Analgesia for pediatric thoracostomy tube removal.  Anesth Analg. 2000;  90 1025-1028